MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

Search

Globus Medical Inc (Class A)

Закрыт

СекторЗдравоохранение

92.88 0.29

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

91.59

Макс.

93.4

Ключевые показатели

By Trading Economics

Доход

-84M

119M

Продажи

24M

769M

P/E

Средняя по отрасли

30.249

89.037

Прибыль на акцию

1.18

Рентабельность продаж

15.469

Сотрудники

5,300

EBITDA

22M

215M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+14.14% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

24 февр. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

4.4B

13B

Предыдущая цена открытия

92.59

Предыдущая цена закрытия

92.88

Новостные настроения

By Acuity

21%

79%

36 / 352 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Globus Medical Inc (Class A) График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

26 янв. 2026 г., 23:49 UTC

Популярные акции

Stocks to Watch: Agilysys, Nucor, Humana, UnitedHealth

26 янв. 2026 г., 23:09 UTC

Главные движущие силы рынка

Health Insurers' Shares Fall After Government Proposes Flat Medicare Advantage Rate

26 янв. 2026 г., 23:52 UTC

Обсуждения рынка

Gold's Path of Least Resistance Still Looks Higher, Technical Analysis Shows -- Market Talk

26 янв. 2026 г., 23:46 UTC

Обсуждения рынка

Nikkei May Decline as Yen's Rebound Raises Caution Over Earnings -- Market Talk

26 янв. 2026 г., 23:37 UTC

Обсуждения рынка

Gold Rises Amid Concerns Over Tariffs -- Market Talk

26 янв. 2026 г., 22:41 UTC

Обсуждения рынка

Australian 4Q CPI To Provide Smoking Gun For Hike -- Market Talk

26 янв. 2026 г., 22:26 UTC

Отчет

Karoon Expects Capex of US$110 Million-US$135 Million in 2026

26 янв. 2026 г., 22:26 UTC

Отчет

Karoon Expects Operating Costs to Fall Once Transition of Bauna FPSO Operatorship Completes

26 янв. 2026 г., 22:25 UTC

Отчет

Karoon Energy Expects Unit Production Cost of US$12-US$15/BOE in 2026

26 янв. 2026 г., 22:25 UTC

Отчет

Karoon Energy Expects Output to Rise in 2H Following Bauna Investment Program

26 янв. 2026 г., 22:25 UTC

Отчет

Karoon Energy Expects Output of 8.1 Million-9.2 Million BOE in 2026

26 янв. 2026 г., 22:24 UTC

Отчет

Karoon Energy 4Q Sales Revenue US$156.1 Million

26 янв. 2026 г., 22:23 UTC

Отчет

Karoon Energy 4Q Sales Volumes 2.65 Million BOE, Up 5% on Quarter

26 янв. 2026 г., 22:23 UTC

Отчет

Karoon Energy: Bauna FPSO Efficiency Increased to 98.8%

26 янв. 2026 г., 22:23 UTC

Отчет

Karoon Energy FY Oil, Natural Gas Production 10.3 Million BOE

26 янв. 2026 г., 22:22 UTC

Отчет

Karoon Energy 4Q Oil, Natural Gas Production 2.37 Million BOE

26 янв. 2026 г., 22:05 UTC

Приобретения, слияния, поглощения

Fortescue: Alta Copper Shareholders Approve Takeover

26 янв. 2026 г., 22:02 UTC

Приобретения, слияния, поглощения

Senate Antitrust Panel Chair Raises Concerns Over Netflix-Warner Deal -- WSJ

26 янв. 2026 г., 21:50 UTC

Обсуждения рынка
Отчет

Financial Services Roundup: Market Talk

26 янв. 2026 г., 21:50 UTC

Обсуждения рынка

Auto & Transport Roundup: Market Talk

26 янв. 2026 г., 21:34 UTC

Отчет

Nucor: Steel Products Segment Expected Improved Earnings in 1Q Due to Increased Volumes on Stable Pricing >NUE

26 янв. 2026 г., 21:34 UTC

Отчет

Nucor: Steel Mills Segment Expected Increase Is Due to Higher Volumes and Higher Realized Prices Across All Major Pdt Categories >NUE

26 янв. 2026 г., 21:34 UTC

Отчет

Nucor: Raw Materials Segment Is Expected to Have Increased Earnings in 1Q >NUE

26 янв. 2026 г., 21:34 UTC

Отчет

Nucor: 1Q Earnings Expected to Increase Across All Three Operating Segments, With the Largest Increase in Steel Mills Segment >NUE

26 янв. 2026 г., 21:30 UTC

Приобретения, слияния, поглощения

Eaton Stock Rises on Spin-Off Plan. Why It's Going All-In on Planes and AI Data Centers. -- Barrons.com

26 янв. 2026 г., 21:30 UTC

Отчет

Nucor 4Q Sales $7.69B >NUE

26 янв. 2026 г., 21:30 UTC

Отчет

Nucor 4Q Net $378M >NUE

26 янв. 2026 г., 21:30 UTC

Отчет

Nucor 4Q Steel Mills Total Shipments 5.91M Tons >NUE

26 янв. 2026 г., 21:30 UTC

Отчет

Nucor 4Q Total Tons Shipped to Outside Customers Down 9% >NUE

26 янв. 2026 г., 21:30 UTC

Отчет

Nucor 4Q EPS $1.64 >NUE

Сравнение c конкурентами

Изменение цены

Globus Medical Inc (Class A) Прогноз

Целевая цена

By TipRanks

14.14% рост

Прогноз на 12 месяцев

Средняя 105.6 USD  14.14%

Максимум 118 USD

Минимум 87 USD

Основано на мнении 13 аналитиков Wall Street, спрогнозировавших целевые цены для Globus Medical Inc (Class A) на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

13 ratings

9

Покупка

4

Удержание

0

Продажа

Техническая оценка

By Trading Central

72.18 / 73.07Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Weak Bearish Evidence

Настроения

By Acuity

36 / 352Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat